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In Low and Middle-Income Countries (LMIC), weaning is associated with environmentally
acquired and inflammation-associated enteric disorders. Dietary intake of high amylose
maize starch (HAMS) can promote commensal fermentative bacteria and drive
the production of short chain fatty acids (SCFAs). By stabilizing commensal gut
microbiology, and stimulating the production of anti-inflammatory metabolites, HAMS
supplementation might therefore influence enteric health. However, the extent to which
the gut microbiota of LMIC infants are capable of fermenting HAMS is unclear. We
assessed the capacity of the fecal microbiota from pre-weaning and weaning Malawian
infants to ferment HAMS and produce SCFAs using an in vitro fermentation model.
Fecal microbiota from both pre-weaning and weaning infants were able to ferment
HAMS, as indicated by an increase in bacterial load and total SCFA concentration, and
a reduction in pH. All of these changes were more substantial in the weaning group.
Acetate production was observed with both pre-weaning and weaning groups, while
propionate production was only observed in the weaning group. HAMS fermentation
resulted in significant alterations to the fecal microbial community in the weaning group,
with significant increases in levels of Prevotella, Veillonella, and Collinsella associated
with propionate production. In conclusion, fecal microbiota from Malawian infants before
and during weaning has the capacity to produce acetate through HAMS fermentation,
with propionate biosynthetic capability appearing only at weaning. Our results suggest
that HAMS supplementation might provide benefit to infants during weaning.
Keywords: high-amylose maize starch, weaning, fermentation, short chain fatty acids, fecal microbiota
INTRODUCTION
Infants in Low and Middle-Income Countries (LMIC) are at high risk of environmentally acquired
and inflammation-associated enteric disorders, including Environmental Enteric Dysfunction
(EED). EED is an environmentally acquired gut disorder characterized by global disturbance of
intestinal structure and function (Owino et al., 2016) that results from the cumulative impact of
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enteric infections. The characteristics of EED include enteric and
systemic inflammation (Syed et al., 2016; Harper et al., 2018) and
the condition is strongly associated with undernutrition, reduced
growth rate and cognitive defects in LMIC infants (Owino et al.,
2016). Poor sanitation and the microbial contamination of food
and water supplies in LMIC contribute to high rates of enteric
infection and EED (Korpe and Petri, 2012; Ali et al., 2016).
While the pathogenesis of EED is complex, the condition
is both preventable and reversible (Owino et al., 2016).
In addition to limiting the exposure of infants to enteric
pathogens, reducing inflammation and restoring commensal gut
microbiology are believed to be potential therapeutic strategies
(Syed et al., 2016). Prebiotics might therefore provide benefit,
by supporting the growth of commensal microbes, and by
promoting the production of beneficial microbial metabolites
(Gibson et al., 2017), including short chain fatty acids (SCFAs).
SCFAs (predominantly acetate, butyrate and propionate) reduce
local and systemic inflammation (Vinolo et al., 2011), and
butyrate contributes to the maintenance of gut barrier function
(Peng et al., 2009; Canani et al., 2011).
The potential prebiotic properties of high amylose maize
starch (HAMS), a type 2 dietary resistant starch (RS), have been
demonstrated previously (Zaman and Sarbini, 2016). HAMS
promotes the growth of important commensal bacteria, including
members of the Bifidobacterium genus. HAMS also drives SCFA
production (Morita et al., 1998; Le Leu et al., 2009), a function
that can result in reduced inflammation and improved gut health,
as demonstrated both rodent models (Le Leu et al., 2009) and
healthy adults (van Munster et al., 1994).
The transition from exclusive breastfeeding to complementary
food intake (weaning) presents heightened risks for EED due
to for the increased exposure to enteric pathogens through
faeco-oral contamination (Motarjemi et al., 1993; Crane et al.,
2015). In Malawi, the prevalence of diarrhoeal diseases rises
sharply from 13% before weaning age to 41% at 6–12 months
(National Statistical Office and The DHS Program ICF, 2017).
Enteric health during this period is therefore likely to be critical
in EED development. However, weaning also represents a first
opportunity for dietary interventions that stabilize commensal
gut microbiology and reduce inflammation.
HAMS has Generally Recognized as Safe (GRAS) status.
Additionally, it is inexpensive, and does not alter the taste or
textural properties when added to food (Brown, 1996). Maize
is a common food in Malawi, used widely as a weaning food
(Kerr et al., 2007). This enables the ready addition of HAMS
to typical weaning foods, without disrupting existing dietary
practices. Because HAMS is highly resistant to human digestive
enzymes, it passes into the large intestine to provide a potential
fermentative substrate, allowing increased production of SCFAs.
However, the few studies that have assessed the potential of
HAMS supplementation to support gut health in LMIC children
have produced inconsistent findings. A study in Indian children
aged between 6 months to 3 years reported that the addition of
HAMS to oral rehydration solution (ORS) significantly reduced
the duration of diarrhea, compared to standard glucose ORS
treatment alone (Raghupathy et al., 2006), suggesting that this
approach can provide benefit. In contrast, the provision of
doughnuts containing 8.5 g/d of HAMS to stunted Malawian
children aged 3–5 years resulted in no improvement of gut
inflammation, with increased levels of the gut inflammatory
marker calprotectin, and decreased levels of acetate, compared to
placebo (Ordiz et al., 2015).
Weaning of infants in Malawi typically starts at a younger
age than the 6 months (Kerr et al., 2007) recommended by the
World Health Organization [WHO], 2018. It is unclear whether
the gut microbiota is sufficiently developed in infants of this age
to ferment HAMS, and thereby provide benefit, given the typical
absence or low abundance of bacterial clades able to ferment
polysaccharides (Arrieta et al., 2014; Backhed et al., 2015).
Therefore, before HAMS can be assessed as a potential strategy to
prevent or treat EED, the capacity of the gut microbiota of infants
in low-income country settings to ferment HAMS and produce
SCFAs must be determined.
We report an investigation of the capacity of fecal microbiota
from Malawian infants to utilize HAMS and produce SCFAs
within an in vitro fermentation system, and describe the impact of
this process on the composition of fecal microbiota. To assess the
development of fermentative capacity during this transitionary
period, and therefore whether HAMS might represent a potential
first weaning food, our analysis included samples from both
weaning and pre-weaning infants.
MATERIALS AND METHODS
Study Population
The study was conducted according to the principles expressed
in the Declaration of Helsinki, and all research procedures
were approved by the Southern Adelaide Clinical Human
Research Ethics Committee (SACHREC) for Flinders University
(504.14-HREC/14/SAC/541) and the University of Malawi
College of Medicine Research Ethics Committee (COMREC)
(P.08/15/1781). In addition, a study approval letter was
provided through the Neno District Health Office, authorizing
the involvement of the Neno District Hospital. Written
informed consent was obtained from all caregivers of the
participating children.
Fecal samples were collected from infants attending the
Neno District Hospital for routine child health checks between
November 2015 and March 2016. Inclusion criteria for the
participating infants were full-term pregnancy (≥37 weeks
gestation) and vaginal birth. Infants who had antibiotic exposure
or acute gastrointestinal illness within 2 weeks prior to sample
collection, or had acute or major systemic disease, including
HIV/AIDS, were excluded. Feeding practices reported by
caregivers were recorded using a standardized template. Infants
who were exclusively breast fed were classified as “pre-weaning.”
Infants within 5 months of commencing complementary foods
(partially breast fed) were classified as “weaning.”
Sample Collection
Stool collection was performed using a disposable nappy with
a plastic lining insert, which was fastened to the infant
by study staff. Caregivers were asked to alert study staff
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when the infant had passed a stool. Nappies were removed
immediately and a sterile spatula was used to transfer stool
to 2 mL cryovials. Samples were immediately frozen in liquid
nitrogen for shipment to the South Australian Health and
Medical Research Institute, Adelaide, for analysis. Five samples
were excluded due to insufficient volume for conducting the
fermentation assay (<300 mg) and 34 samples were used for
in vitro fermentation.
In vitro Fermentation
To simulate gastric and small intestinal starch digestion
in infants, HAMS (Hylon VII, Ingredion Incorporated) was
pre-digested by an in vitro method adapted from a previous
study (Woolnough et al., 2010; Wang et al., 2018). Full details of
HAMS pre-digestion and preparation procedures are included as
Supplementary Methods. The pre-digested HAMS was air-dried
and sterilized by UV for 1 h.
The in vitro fermentation protocol was developed based
on a previously described method (Wang et al., 2018) with
modifications. In brief, a basal medium (pH 6.8) that contained
tryptone (2.5 g/L), yeast extract (0.5 g/L) and mineral salts
adapted from McSweeney et al. (2005) was used as fermentation
medium. Resazurin solution was used as the oxidation-reduction
indicator. The medium was boiled and cooled in the anaerobic
hood, prior to the addition of cysteine HCl. Ingredients of the
fermentation medium is included in Supplementary Table 1. Ten
milliliter of medium was transferred under anaerobic conditions
to Hungate tubes, which were stoppered and autoclaved.
Fecal sample and pre-digested HAMS were dissolved in
anaerobic diluent (pH 6.8) for preparing the slurry. One
mL of fecal slurry (with 100 mg of feces) and 0.5 ml of
HAMS slurry (with 100 mg of HAMS) were injected to the
fermentation tubes containing 10 ml of basal medium under
anaerobic conditions. The level of HAMS used was selected to
provide continuity with previous in vitro investigation in other
subject populations (Edwards et al., 1996) and is not necessarily
a concentration that would be achieved in vivo. Control
fermentation tubes were prepared with 0.5 ml of anaerobic
diluent in place of HAMS slurry. Following inoculation,
Hungate tubes were incubated at 37◦C for 24 h with constant
shaking at 150 rpm.
Determination of pH and SCFA Levels
Post-fermentation, samples were centrifuged at 13,000 g,
4◦C, for 10 min. Supernatant pH was determined before
and after fermentation using a pH meter (Mettler-Toledo
Ltd.). Samples for SCFA measurement were prepared from
pre- and post-fermentation supernatant using a water-extraction
method modified from Zhao et al. (2006). 4-Methylvaleric
acid (Sigma-Aldrich) was used as an internal standard. SCFA
concentrations were determined by gas chromatography (GC,
Agilent Technologies 7890A, Agilent Technologies, Santa Clara,
CA, United States) fitted with a flame ionization detector (Agilent
Technologies, Santa Clara, CA, United States). Details of GC
column and running conditions were included in the method
section of Supplementary Material.
DNA Extraction
DNA extraction was performed using a Mo Bio PowerLyzer
PowerSoil R© 96 Well DNA isolation kit (Mo Bio Laboratories).
Manufacturer’s instructions were modified as follows: Samples
were added into bead tubes with solution C1 and heated at 65◦C
for 10 min, prior to two cycles of bead beating at 6.5 m/s for
1 min using a FastPrep-24 bead beater (MP Biomedicals). DNA
concentrations were quantified fluorometrically with a Quant-iT
dsDNA Assay kit (Life Technologies).
Quantitative PCR and 16S rRNA Gene
Amplicon Sequencing
qPCR was performed to determine the absolute levels of
total bacteria using methods described previously (Nadkarni
et al., 2002). Amplicon sequencing of the V4 hypervariable
region of the bacterial 16S rRNA gene was performed as
described previously (Choo et al., 2015) using an Illumina MiSeq
platform. Paired-end16S rRNA gene amplicon sequence reads
were analyzed with quantitative insights into microbial ecology
(QIIME) software (v1.8.0) (Caporaso et al., 2010). The datasets of
16S rRNA gene sequence for this study can be found in the NCBI
Sequence Read Archive under accession number PRJNA516214.
Statistical Analysis
Normality of data distribution was assessed using the
Shapiro–Wilk test. Intergroup differences in bacterial load
at baseline were assessed using Mann–Whitney U-test
(pre-weaning vs. weaning) and in measures of fermentation
outcomes using Wilcoxon rank-sum tests (HAMS vs. Control)
(GraphPad Prism version 7.00). Intergroup differences in
microbiota β-diversity were assessed using the permutational
analysis of variance (PERMANOVA) model, based on the
parameters’ permutation of residuals under a reduced model
and a type III sum of squares (Primer-E v.7; Primer-E Ltd.,
Plymouth, United Kingdom) (Anderson and Walsh, 2013).
Nonmetric multidimensional scaling (nMDS) plots were
generated using weighted UniFrac distances. Differences of
microbiota membership between pre-weaning and weaning
groups at different taxonomic levels were analyzed by LEfSe
(Galaxy application tool1) using linear discriminant analysis
(LDA) scores > 2. Correlation between SCFA concentrations
and taxa were performed using Spearman rank correlation
(GraphPad Prism). Values in text were presented as median
(interquartile range).
RESULTS
Baseline Microbiota Composition
Thirty-four samples (11 pre-weaning, 23 weaning) that had
sufficient volume for performing the in vitro fermentation were
used in the study. Infant characteristics are provided in Table 1.
Analysis was performed on all samples prior to, and following,
in vitro fermentation. One pre-fermentation sample (weaning)
1 http://huttenhower.sph.harvard.edu/galaxy/
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TABLE 1 | Participant characteristics.1
Pre-weaning (n = 11) Weaning (n = 23)
Age at sampling (month) 2.9 (1.5–4.5) 5.6 (3.0–10.5)
Weight (kg) 6.4 (4.5–7.5) 7.3 (5.0–10.3)
Length (cm) 61.5 (54.0–65.8) 67.0 (55.2–79.0)
Stunted2 (n) 2 1
Feeding practice Exclusive breastfeeding Mixed feeding of breast
milk and
complementary foods3
1All infants were vaginally delivered and had no antibiotic intake for two weeks prior
to sample collection (inclusion criteria). Data are presented as median (min–max).
2Stunting is defined as length-for-age below −2 z-scores of WHO Child Growth
Standards. 3Main type of complementary foods include Cerelac (Nestle), Likuni
Phala (Malawi product, Maize-based infant cereal) or home-made maize porridge.
failed to achieve sufficient sequence read depth and was excluded
from further analysis. Analysis of the composition of fecal
microbiota from Malawian infants (pre-fermentation) showed it
to be dominated by members of the Bifidobacterium, Veillonella,
and Escherichia-Shigella genera (data not shown).
Substantial differences in fecal microbiota were observed
between pre-weaning and weaning groups prior to fermentation.
Weaning samples showed higher OTU richness (P = 0.0007,
Figure 1A) and higher phylogenetic diversity compared to
pre-weaning samples (P = 0.0006, Figure 1B). No significant
difference was detected in the composition of the fecal microbiota
as a whole in pre-weaning and weaning samples (based on
weighted UniFrac distances) (PERMANOVA, P = 0.18, data
not shown). However, significant differences in the relative
abundance of specific taxa were identified (Figure 2). Samples
from pre-weaning infants had a significantly greater relative
abundance of the Actinobacteria phylum (LDA = 4.9, Figure 2),
which were predominantly members of the Bifidobacterium
genus. Weaning samples exhibited higher levels of Prevotella,
Lactobacillus, Allobaculum, Weissella, Dorea, Akkermansia, and
Haemophilus genera (LDA > 2, Figure 2). Most of these taxa
were absent or present at extremely low relative abundance in
pre-weaning samples, with the exception of Lactobacillus.
FIGURE 1 | Alpha diversity of pre-weaning and weaning pre-fermentation
fecal microbiota. (A) Taxa richness (observed OTUs) and (B) Faith’s
phylogenetic diversity. Significance was determined by Mann–Whitney U test
with P < 0.05. ∗∗P < 0.01.
Changes in pH and Bacterial Load
Resulting From HAMS Fermentation
Fermentation of HAMS resulted in increased total bacterial load
and reduced medium pH for both pre-weaning and weaning
samples (Figure 3). Median total bacterial load increased 4.5-fold
for pre-weaning (P = 0.002)and more than 7-fold for weaning
(P = 0.001), compared to controls (Figure 3A). Correspondingly,
pH of the fermentation medium dropped by 0.65 for pre-weaning
(P = 0.001) and 0.99 units for weaning samples (P < 0.0001,
Figure 3B). The change in bacterial load and pH were not
significantly greater in the weaning group compared to the
pre-weaning group.
Changes in Fecal Microbiota Resulting
From HAMS Fermentation
Fermentation of HAMS resulted in a significant shift in
microbiota composition in weaning samples (weighted UniFrac
Distance, HAMS vs. Control, PERMANOVA, P < 0.05,
Supplementary Figure 1B). Changes in microbiota composition
in pre-weaning samples did not achieve statistical significance
(Supplementary Figure 1A). Specifically, the relative abundance
of Bifidobacterium, Veillonella, Collinsella, and Prevotella
were significantly higher in weaning samples compared
to control following HAMS fermentation (Figures 4A–D),
while Enterobacter and Peptoniphilus were significantly
lower (Figures 4E,F). However, these taxa showed no
significant differences in relative abundance compared to
controls for the pre-weaning group (Figures 4A–F). In
contrast, the relative abundance of Clostridium sensu stricto
1 (Clostridium ss1) increased significantly in pre-weaning
group compared to control, but not in the weaning group
(Figure 4G). Relative abundance of Escherichia-Shigella
decreased in both pre-weaning and weaning samples compared
to control (Figure 4H).
Changes in SCFAs Resulting From HAMS
Fermentation
HAMS fermentation resulted in significant increases in the
levels of acetate compared to controls for both pre-weaning and
weaning groups (Figure 5). Propionate concentrations increased
in response to HAMS in the weaning group (Figure 5B), but
not in the pre-weaning group (P = 0.70, Figure 5A). Total
SCFA levels also increased in both pre-weaning and weaning
groups (P = 0.0001, Figures 5A,B) largely reflecting increases
in acetate. Butyrate levels did not increase significantly in either
pre-weaning or weaning samples.
To identify the bacteria taxa that are likely to contribute to
SCFA production, the relative abundance of taxa that showed
a significant increase or decrease during HAMS fermentation
was correlated to post-fermentation levels of acetate and
propionate. Significant correlations were observed only for
weaning samples. The relative abundances of Veillonella and
Prevotella were positively correlated with levels of both acetate
and propionate (Table 2). Collinsella, a genus belonging to
the Actinobacteria phylum, also showed a positive correlation
with propionate (Table 2). Escherichia-Shigella and Clostridium
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FIGURE 2 | LEfSe cladogram showing microbial members at different taxonomical levels that differed between pre-weaning and weaning infants at baseline. A linear
discriminant analysis score (LDA) cut-off of 2 was employed. c, class; p, phylum.
FIGURE 3 | Total bacterial load and pH post-fermentation for pre-weaning
(blank) and weaning (shaded) groups. (A) Total bacterial load
post-fermentation for fecal samples fermented with and without HAMS
(control). (B) pH post-fermentation for fecal samples fermented with HAMS
and control. Significance was determined using Wilcoxon rank-sum tests with
P < 0.05. ∗P < 0.05; ∗∗P < 0.01, ∗∗∗P < 0.001.
ss1, which showed significant decreases in relative abundance
during HAMS fermentation, were negatively correlated with
post-fermentation propionate concentration (Table 2).
DISCUSSION
We assessed the capacity of the fecal microbiota from infants
in a rural location in Malawi to ferment the type 2 RS, HAMS.
The study population was subject to many of the factors that
contribute to the burden of disease from EED in the developing
world, including limited sanitation, water treatment processing,
and public health resources (Owino et al., 2016).
Overall, the characteristics of the fecal microbiota of these
Malawian infants were in keeping with those reported for
infants in developed countries (Backhed et al., 2015; Murphy
et al., 2017). Consistent with previous analyses of infant fecal
microbiota composition (Backhed et al., 2015), pre-weaning
samples exhibited significantly lower microbiota richness and
diversity, compared to samples from weaning infants. The
microbiota of pre-weaning fecal samples were dominated by
Bifidobacterium and Veillonella, typical early colonizers of the
human gut (Murphy et al., 2017). While many members of the
Bifidobacterium genus are able to produce acetate through the
degradation of a wide range of carbohydrates, including starch
(Pokusaeva et al., 2011), particular species that are common in the
infant gut (e.g., Bifidobacterium longum) may lack this capacity
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FIGURE 4 | Taxa changed during fermentation with and without HAMS (control) for pre-weaning (blank) and weaning (shaded). Significance was determined using
Wilcoxon rank-sum test with P < 0.05. ∗P < 0.05; ∗∗P < 0.01, ∗∗∗P < 0.001. (A) Bifidobacterium, (B) Veillonella, (C) Collinsella, (D) Prevotella, (E) Enterobacter,
(F) Peptoniphilus, (G) Clostridium ss1, and (H) Escherichia-Shigella.
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FIGURE 5 | SCFA concentrations for pre-weaning (A) and weaning (B)
groups post-fermentation with and without HAMS (control). Significance was
determined using Wilcoxon rank-sum tests with P < 0.05. ∗P < 0.05;
∗∗P < 0.01, ∗∗∗P < 0.001.
(Ryan et al., 2006), instead primarily metabolizing human milk
oligosaccharides (Garrido et al., 2011; Ruiz-Moyano et al., 2013).
Veillonella species, in contrast, are unable to utilize
carbohydrates, and instead exploit lactate and succinate
TABLE 2 | Correlation between SCFAs and taxa that were changed by HAMS
during fermentation.1
SCFA Taxon rs P-value
Acetate
Prevotella 0.42 0.044
Veillonella 0.50 0.016
Clostridium ss1 −0.46 0.028
Propionate
Collinsella 0.55 0.0065
Prevotella 0.45 0.032
Veillonella 0.78 <0.0001
Escherichia-Shigella −0.55 0.0066
1Only significant correlations from weaning group are shown. No significant
correction was observed in pre-weaning group using Spearman rank correlation
test. Clostridium ss1, Clostridium sensu stricto1.
produced by other taxa during carbohydrate-degradation
(Rainey, 2009). Common starch-utilizing taxa, including
the Prevotella and Dorea genera, were not detected in the
pre-weaning samples.
The fecal microbiota of weaning infants, while still dominated
by the Bifidobacterium and Veillonella genera, contained
an abundance of carbohydrate-degrading bacteria. These
included the Prevotella, Bacteroides, and Faecalibacterium
genera. The difference in composition between the infant
groups is likely to reflect the introduction of solid foods during
weaning, a process that helps to shape the developing gut
microbiota by providing new substrates for bacterial growth
(Fallani et al., 2011).
An in vitro fermentation model that mimics fermentation in
the infant gut allows the preliminary assessment of the microbial
capacity to utilize HAMS in a safe and defined pre-clinical
setting. Compositional differences between pre-weaning and
weaning fecal microbiota were reflected in their response
to HAMS during in vitro fermentation. HAMS fermentation
occurred in both sample groups, as indicated by an increase
in bacterial cell numbers, a drop in pH, and an increase
in SCFA concentrations. However, fecal microbiota β-diversity
(an indicator of change in overall microbiota composition
between pre- and post-fermentation) with HAMS were modest
and significant only in the weaning group, suggesting that
HAMS does not represent a strong selective pressure across
all taxa, with an effect that is limited to a discrete group
of taxa. While post-fermentation concentrations of acetate
were increased in both groups, the correlations with bacterial
taxa were substantially weaker for pre-weaning microbiota, an
observation that might be explained by the limited presence
of acetate-producers in the immature pre-weaning microbiota.
For example, the absence of the acetate-producing Prevotella
genus in breast-fed pre-weaning samples might be explained
by its association with plant-derived dietary carbohydrates
(Martinez et al., 2015; De Filippis et al., 2016). Similarly, the
introduction of complementary foods is likely to underpin
the increased diversity of fermentative taxa in the weaning
group more widely.
Propionate production was only observed in weaning
samples, and was positively correlated with Prevotella, Collinsella,
and Veillonella relative abundance. The apparent involvement
of these three taxa in SCFA production might reflect a
metabolic interaction between members of these genera. Many
Collinsella and Prevotella species do not produce propionate,
but can produce substantial amounts of succinate through
carbohydrate fermentation (Kageyama and Benno, 2012; De
Vadder et al., 2016). In contrast, most of the members of
the Veillonella genus are unable to ferment carbohydrates, but
can produce propionate through the fermentation of succinate
(Rainey, 2009).
The absence of significant butyrate biosynthesis in either
pre-weaning or weaning samples during HAMS fermentation,
with SCFA production largely limited to acetate and propionate,
is consistent with previous infant studies (Parrett et al.,
2003; Scheiwiller et al., 2006)and is in contrast to adults
(Parrett and Edwards, 1997). Indeed, bacterial taxa that are
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responsible for butyrogenesis in the human gut, including
Faecalibacterium prausnitzii, Eubacterium rectale, Roseburia
faecis, and other members of Clostridium clusters IV, XIVa,
and XVI (Louis et al., 2004; Louis et al., 2010), were absent
or present in very low relative abundances in the infant fecal
samples assessed here.
Bifidobacterium is typically the most prevalent genus in the
infant gut microbiota (Kleessen et al., 1995) and can provide
protection against infection by enteropathogens through the
production of acetate, and the promotion of gut barrier function
(Fukuda et al., 2011). Resistant starch has been shown to increase
the relative abundance of bifidobacteria in a porcine model
(Fouhse et al., 2015). In our study, we observed a substantial
increase in bifidobacteria in the weaning group only, but the
absence of such an effect in pre-weaning infants. This difference
is likely to reflect the inability of bifidobacteria to utilize HAMS,
and their reliance on the presence of primary polysaccharide
degraders (Liu et al., 2015); which were only observed following
the introduction of complementary foods.
The observed decrease in the relative abundance of
Escherichia-Shigella resulting from HAMS fermentation in
both pre-weaning and weaning groups might be of clinical
relevance. The Escherichia-Shigella group contains many
pathogens that are strongly associated with intestinal infection
and EED risk, including pathogenic Escherichia coli (E. coli)
(Crane et al., 2015). A significant negative correlation was
observed between Escherichia-Shigella relative abundance and
the propionate biosynthesis in the weaning group, and a similar
relationship with acetate levels trended toward significance
(data not shown). This effect might reflect the production of
acid during fermentation (including lactate and SCFAs) and the
resulting decrease in pH. It has been shown in vitro that the
growth of pathogenic E. coli can be substantially suppressed by
low pH and presence of SCFAs (Shin et al., 2002). Additionally,
the ability of high SCFA levels and low pH to inhibit intestinal
colonization by pathogenic Shigella sonnei and E. coli has been
demonstrated previously in a mouse model (Pongpech and
Hentges, 1989). The ability of HAMS fermentation to inhibit the
growth of Escherichia-Shigella might therefore provide additional
clinical benefit.
Our findings suggest that HAMS supplementation in
Malawian infants might provide benefits to gut health, and by
extension, early life development. Whilst ensuring that exclusive
breastfeeding for the first 6 months of life is not disturbed,
there is already strong support for the inclusion of RS as HAMS
into ORS (Ramakrishna et al., 2008; Binder et al., 2014). The
consumption of ORS to prevent dehydration when diarrhea is
present is recommended in the WHO guidelines for exclusive
breastfeeding (Victora et al., 2016). The ability of SCFAs to
stimulate colonic sodium and fluid absorption via acyclic
AMP-independent mechanism (Binder et al., 2014) warrants
further consideration in support of including HAMS in the
ORS formulation. The potential microbiome-mediated benefits
of such an intervention should also be considered further. In
weaning and older infants, replication of our microbiological
findings through feeding studies in Malawian infants, in
conjunction with the demonstration of associated health benefits
would support the inclusion of HAMS as a supplement to the
typical diet for this population.
This study had a number of limitations that should
be considered. First, the weaning group contained infants
transitioning to a range of foods, and with likely variation in the
relative consumption of breast milk. These are factors that are
likely to influence microbiota composition. However, the cohort
was not sufficiently large, nor was food intake data sufficiently
detailed, to relate dietary habit to HAMS response within this
population. Second, while considerable efforts were made to
ensure the integrity of samples shipped from Malawi to Australia
for analysis, it is not possible to determine with certainty whether
this process effected overall microbial viability or the relative
viability of specific taxa. Third, the in vitro fermentation system
used to assess HAMS utilization does not fully replicate the
conditions within the infant gut. This approach merely provides
a broad indication of the capacity of gut microbiota to utilize
HAMS to produce SCFA, and the taxa that are largely responsible.
Fourth, HAMS was assessed relative to a no substrate control,
rather than alternative fermentation substrates. Fifth, the extent
to which HAMS supplementation results in increased SCFA
production in vivo can only be determined through an infant
feeding study. Such a study would further allow response to
HAMS supplementation to be linked to potential enteric health
and developmental benefits.
In summary, the fecal microbiota of Malawian infants
before and during weaning have the ability to ferment
HAMS and produce beneficial metabolites, in particularly
acetate. The capability of propionate production through
HAMS fermentation may only develop when bacterial species
that represent primary starch degraders begin to colonize
the gut following the introduction of complementary foods.
Consistently, the impact of HAMS on the composition of the fecal
microbiota was more profound during weaning. In particular,
HAMS was associated with the promotion of important
commensal bacteria, including members of the Bifidobacterium,
Prevotella, Veillonella, Collinsella, and Clostridiums ss1 genera,
and a reduced prevalence of Escherichia-Shigella, Enterobacter,
and Peptoniphilus. These findings support the concept that
HAMS might be an effective and beneficial fermentable
polysaccharides for feeding to infants during weaning. In vivo
studies to explore this potential are therefore indicated.
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